CNN-XG: A Hybrid Framework for sgRNA On-Target Prediction.
PMID:35327601
Machine Learning in Healthcare.
PMID:35273459
Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and -Cas12a guides in Yarrowia lipolytica.
PMID:35177617
Key sequence features of CRISPR RNA for dual-guide CRISPR-Cas9 ribonucleoprotein complexes assembled with wild-type or HiFi Cas9.
PMID:35166844
High-throughput methods for genome editing: the more the better.
PMID:35134245
Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity.
PMID:35078987
Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
PMID:35078986
AI in health and medicine.
PMID:35058619
Protein-RNA interaction prediction with deep learning: structure matters.
PMID:34929730
AttCRISPR: a spacetime interpretable model for prediction of sgRNA on-target activity.
PMID:34903170
Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell.
PMID:34869290
Uncertainty-aware and interpretable evaluation of Cas9-gRNA and Cas12a-gRNA specificity for fully matched and partially mismatched targets with Deep Kernel Learning.
PMID:34791389
Neuronal Cell-type Engineering by Transcriptional Activation.
PMID:34713262
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System.
PMID:34713256
An easy-to-use CRISPRi plasmid tool for inducible knockdown in E. coli.
PMID:34703773
DeepTrio: a ternary prediction system for protein-protein interaction using mask multiple parallel convolutional neural networks.
PMID:34694333
CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation.
PMID:34526543
Understanding the Potential of Genome Editing in Parkinson's Disease.
PMID:34502143
Genome dependent Cas9/gRNA search time underlies sequence dependent gRNA activity.
PMID:34413309
TSA Promotes CRISPR/Cas9 Editing Efficiency and Expression of Cell Division-Related Genes from Plant Protoplasts.
PMID:34360584
Synthetic biology as driver for the biologization of materials sciences.
PMID:34195591
Gene editing in a Myo6 semi-dominant mouse model rescues auditory function.
PMID:34174443
Generation of locus-specific degradable tag knock-ins in mouse and human cell lines.
PMID:34151298
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning.
PMID:34050182
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs.
PMID:33868784
Prediction of CRISPR/Cas9 single guide RNA cleavage efficiency and specificity by attention-based convolutional neural networks.
PMID:33841753
CRISPR screens in plants: approaches, guidelines, and future prospects.
PMID:33823021
Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy.
PMID:33776777
Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
PMID:33752742
Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants.
PMID:33744974
Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction.
PMID:33691754
CRISPR-based strategies for targeted transgene knock-in and gene correction.
PMID:33659952
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice.
PMID:33558692
A method for characterizing Cas9 variants via a one-million target sequence library of self-targeting sgRNAs.
PMID:33450024
Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library.
PMID:33228647
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
PMID:33208369
Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines.
PMID:33151638
dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells.
PMID:33051688
CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets.
PMID:32811551
CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials.
PMID:32796761
A Generative Neural Network for Maximizing Fitness and Diversity of Synthetic DNA and Protein Sequences.
PMID:32711843
Automated design of a convolutional neural network with multi-scale filters for cost-efficient seismic data classification.
PMID:32620867
Retinal gene therapy: an eye-opener of the 21st century.
PMID:32561864
CRISPRpred(SEQ): a sequence-based method for sgRNA on target activity prediction using traditional machine learning.
PMID:32487025
A Tandem Guide RNA-Based Strategy for Efficient CRISPR Gene Editing of Cell Populations with Low Heterogeneity of Edited Alleles.
PMID:32315231
CGD: Comprehensive guide designer for CRISPR-Cas systems.
PMID:32308928
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
PMID:32292501
Multiplexed CRISPR technologies for gene editing and transcriptional regulation.
PMID:32152313
Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
PMID:31979133
Versatile 3' Functionalization of CRISPR Single Guide RNA.
PMID:31943634